Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationShort Communication

Generation and Characterization of SULT4A1 Mutant Mouse Models

Patrick L. Garcia, Mohammed I. Hossain, Shaida A. Andrabi and Charles N. Falany
Drug Metabolism and Disposition January 2018, 46 (1) 41-45; DOI: https://doi.org/10.1124/dmd.117.077560
Patrick L. Garcia
Department of Pharmacology and Toxicology, and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammed I. Hossain
Department of Pharmacology and Toxicology, and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shaida A. Andrabi
Department of Pharmacology and Toxicology, and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles N. Falany
Department of Pharmacology and Toxicology, and Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Schematic representation of SULT4A1 mutations generated by CRISPR-Cas9. (A) Diagram of the Δ28 mutant SULT4A1 mouse line. CRISPR-Cas9 technology induced a 28-bp deletion within exon 1 that resulted in a frameshift mutation and premature stop codon at AA 62. (B) Diagram of the Δ12 mutant SULT4A1 mouse line. Gene editing induced a 12-bp in-frame deletion of the 4 AA immediately preceding the active site His. For both lines, SULT4A1 female founders were used to establish breeding colonies.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Characterization of SULT4A1 protein expression in Δ28 and Δ12 mutant mouse brains and subcellular localization of WT SULT4A1. WT, heterozygous, and homozygous Δ28 and Δ12 25-day-old mice were euthanized and whole brains were harvested. (A) WT, heterozygous (HET), and homozygous (MUT) Δ28 and Δ12 mice were probed for SULT4A1 protein expression. Human brain cytosol was used as a positive control (CTRL) for SULT4A1. For both strains, WT and heterozygotes showed positive staining for SULT4A1; however, Δ28 and Δ12 homozygotes were negative for SULT4A1. (B) Subcellular fractionation was used to generate nuclear (Nuc), mitochondrial (Mito), cytosolic (Cyto) and microsomal (Micro) fractions from WT adult mouse brain homogenates. Aliquots of each fraction (50 μg) were subjected to SDS-PAGE and immunoblotted for SULT4A1. To determine the purity of subcellular fractions, marker proteins specific to each fraction were probed. Histone H3 was used to probe nuclear fraction purity, mitochondrial import receptor subunit TOM20 homolog (TOM20) was used as a marker protein for the mitochondrial fraction, GAPDH was used as a marker for the cytosolic fraction, and Na+/K+ ATPase was used to determine the microsomal fraction purity. SULT4A1 protein was detected in the mitochondrial, cytosolic, and microsomal fractions, and marker proteins demonstrated pure subcellular fractions.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    SULT4A1 expression in embryo-derived mouse cortical neurons by confocal microscopy. Cortical neurons were harvested from embryonic day-15 mice and grown on cover slips for an additional 12 days prior to immunocytochemistry. Cortical neurons were probed for SULT4A1 expression using a rabbit polyclonal IgG at a 1:5000 dilution. Nuclei were labeled with Hoechst (1:20,000) with primary cortical neurons being positive (green) for SULT4A1 protein in both the soma and neurites, but not in the nuclei (blue).

Additional Files

  • Figures
  • Data Supplement

    • Supplemental Data -

      Supplemental Methods

      Supplemental Figure 1 -  Electropherogram tracings confirm mutational status of SULT4A1 was
      conserved in offspring of Δ28 and Δ12 founders

    • Movie 1  -

      Δ28 and Δ12 homozygous mutant mice display severe neurological deficits

    • Movie 2
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 46 (1)
Drug Metabolism and Disposition
Vol. 46, Issue 1
1 Jan 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Generation and Characterization of SULT4A1 Mutant Mouse Models
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationShort Communication

SULT4A1 Mutant Mouse Models

Patrick L. Garcia, Mohammed I. Hossain, Shaida A. Andrabi and Charles N. Falany
Drug Metabolism and Disposition January 1, 2018, 46 (1) 41-45; DOI: https://doi.org/10.1124/dmd.117.077560

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Rapid CommunicationShort Communication

SULT4A1 Mutant Mouse Models

Patrick L. Garcia, Mohammed I. Hossain, Shaida A. Andrabi and Charles N. Falany
Drug Metabolism and Disposition January 1, 2018, 46 (1) 41-45; DOI: https://doi.org/10.1124/dmd.117.077560
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communication

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics